SCHEMBL5608315

SCHEMBL5608315

OCC1(O)C=C(Br)C(c2ccccc2)C(c2ccoc2)=C1

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6058559 0.79 KDM1A (0.41) KDM1A
SCHEMBL8736634 0.73 KDM1A (0.36) KDM1A
SCHEMBL5608796 0.69 KDM1A (0.33) KDM1A
SCHEMBL8737332 0.69 KDM1A (0.33) KDM1A
SCHEMBL8735310 0.59 KDM1A (0.33) KDM1A
SCHEMBL7398947 0.57 KDM1A (0.39) KDM1A
SCHEMBL8735355 0.57 MAPT (0.34)
SCHEMBL28749556 0.56 ALDH1A1 (0.54)
SCHEMBL1126802 0.56 ALDH1A1 (0.50)
Methyl Alcohol SCHEMBL8745831 0.55 LPL (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833472-A2 USE OF CERTAIN BIPHENYL COMPOUNDS FOR PROTECTION OF NEURONS AND OLIGODENDROCYTES IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS) Aventis Pharmaceuticals Inc. (US) 2007-09-19 EP claimed
WO-2006073726-A2 USE OF CERTAIN BIPHENYL COMPOUNDS FOR PROTECTION OF NEURONS AND OLIGODENDROCYTES IN THE TREATMENT OF MULTIPLE SCLEROSIS (MS) AVENTIS PHARMACEUTICALS INC. (US) 2006-07-13 WO claimed